Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $749408.0.

  • Cryo Cell International's Net Income towards Common Stockholders fell 2874.18% to $749408.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$788541.0, marking a year-over-year increase of 9116.61%. This contributed to the annual value of $87121.0 for FY2024, which is 10091.5% up from last year.
  • Per Cryo Cell International's latest filing, its Net Income towards Common Stockholders stood at $749408.0 for Q3 2025, which was down 2874.18% from $355785.0 recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Net Income towards Common Stockholders ranged from a high of $1.2 million in Q2 2021 and a low of -$11.2 million during Q4 2023
  • Its 5-year average for Net Income towards Common Stockholders is -$380122.2, with a median of $634719.0 in 2022.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first tumbled by 586362.04% in 2023, then surged by 19676.98% in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's Net Income towards Common Stockholders stood at -$3.6 million in 2021, then soared by 94.85% to -$187638.0 in 2022, then crashed by 5863.62% to -$11.2 million in 2023, then surged by 80.55% to -$2.2 million in 2024, then skyrocketed by 134.43% to $749408.0 in 2025.
  • Its Net Income towards Common Stockholders stands at $749408.0 for Q3 2025, versus $355785.0 for Q2 2025 and $282855.0 for Q1 2025.